Precision medicine approach for high-risk prostate cancer
Swedish Prostate Cancer Initiative for Novel Treatment Regimens - Real, Implementation of Precision Medicine in High-risk Prostate Cancer
Region Västerbotten · NCT06687421
This study is trying to understand the biology of high-risk prostate cancer by collecting samples and information from patients to find better treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5500 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Region Västerbotten (other gov) |
| Locations | 1 site (Umeå) |
| Trial ID | NCT06687421 on ClinicalTrials.gov |
What this trial studies
This observational study aims to perform comprehensive molecular characterization and subtyping of primary tumors in patients with high-risk or metastatic prostate cancer. It involves collecting biological samples such as urine and blood, alongside health economic data and patient questionnaires. The study will also link clinical variables and molecular diagnostic outcomes to identify potential candidates for further clinical trials and to enhance the national medical information system for prostate cancer. Ultimately, it seeks to prioritize biomarkers for developing predictive treatment algorithms.
Who should consider this trial
Good fit: Ideal candidates for this study are men being investigated for suspected prostate cancer who can provide informed consent.
Not a fit: Patients who have difficulties understanding the study information due to linguistic or cognitive reasons may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective treatment strategies for patients with high-risk prostate cancer.
How similar studies have performed: Other studies focusing on molecular characterization in cancer have shown promise, indicating that this approach could yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men investigated for suspected prostate cancer * Signed consent form Exclusion Criteria: * Difficulties understanding information about the study due to linguistic, cognitive or other reason
Where this trial is running
Umeå
- Urology, Umeå University Hospital, Region Västerbotten — Umeå, Sweden (RECRUITING)
Study contacts
- Study coordinator: Andreas Josefsson, MD, PhD
- Email: andreas.josefsson@umu.se
- Phone: +46 907850000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Prostate Cancer